Launch of Peptan IIm B for joint health After the introduction in 2018 of Peptan IIm P – a hydrolyzed collagen type II matrix of porcine origin, Rousselot now launches Peptan IIm B of bovine origin to meet global expectations and add more choice for nutraceutical manufacturers looking to formulate w

SiMoGel allows for the production of nutraceutical gummies using silicon or metal molds, which are easily cleanable and eliminate dust during production, unlike traditional starch trays. SiMoGel also significantly reduces setting time to less than 30 minutes, compared to 24 hours for conventional st

Ensuring excellent, customizable sensory properties Consumers today expect the food, health and nutrition products they consume to look, taste and smell good – or even better than imagined. Our extensive Global Sensory Program ensures that the ingredients we offer combine nutritional value and healt

Rousselot revealed the results of a new study which demonstrates that Rousselot’s ultra-pure GMP-grade (1) gelatins outperformed standard non-endotoxin purified research grade gelatins and other coating materials in 2D cell culturing. Data demonstrate that endotoxin (lipopolysaccharide, LPS) levels

Dr. Jeff Daelman Business Development Manager, Innovations Jeff has a bioengineering background and holds a PhD in Applied Biological Sciences. He spent several years working on parenteral process validation at Pfizer, before joining Rousselot’s product and business development team in 2016. What’s

By decoding collagen language, Rousselot has uncovered an extensive library of specific collagen peptide compositions, called Nextida. These compositions can trigger new modes of actions for specific health benefits. A comprehensive testing and validation process involving preclinical and clinical s

The agreement was signed at By-Health’s factory in Zuhai, China. As the first fully transparent factory in the Chinese dietary supplements industry, it was a fitting location to renew the partnership between two companies with a mutual commitment to transparency and traceability. It was this shared

31st conference of the European Society of Biomaterials conference 2021 Session discussion highlights include: Speakers: Dr Jeroen Leijten, University of Twente, Enschede, Netherlands & Dr Jeff Daelman , Business Development Manager, Innovations at Rousselot Biomedical The unique properties of Gelat

Recent research conducted jointly by the University of Twente and Rousselot has highlighted a crucial, often overlooked factor in improving the reliability of 3D in vitro tumor models: the presence of endotoxins. These large, immunogenic molecules, commonly found in the environment, can significantl

The installation of the solar panels on the roofs and facades of Rousselot Girona was completed this spring. Tapping into the region’s humid, subtropical climate – with mild winters and hot summers, during which maximum temperatures typically range from 27 to 37 °C – the new panels represent one mor